Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析

◆英語タイトル:Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1348
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Avadel Pharmaceuticals Plc (AVDL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its proprietary polymer-based technologies: Micropump, an oral sustained release microparticles platform, LiquiTime, a Micropump – derived platform for liquid oral products, Trigger Lock, a Micropump – derived platform that enables abuse-resistant modified and controlled release formulations and Medusa that enables controlled release of injectables. It sells products in the US, France and Ireland. The company operates in St. Louis, Missouri and Charlotte in the US. Avadel is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals Plc Key Recent Developments

Mar 12,2020: Avadel Pharmaceuticals reports fourth quarter and full year 2019 financial results
Feb 21,2020: Avadel Pharmaceuticals announces $65 million Private Placement with leading biotech investment funds
Dec 10,2019: Avadel Pharmaceuticals appoints Dr. Mark McCamish to its board of directors
Oct 04,2019: Avadel announces resignation of Kevin Kotler from board of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Avadel Pharmaceuticals Plc – Key Facts
Avadel Pharmaceuticals Plc – Key Employees
Avadel Pharmaceuticals Plc – Key Employee Biographies
Avadel Pharmaceuticals Plc – Major Products and Services
Avadel Pharmaceuticals Plc – History
Avadel Pharmaceuticals Plc – Company Statement
Avadel Pharmaceuticals Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Avadel Pharmaceuticals Plc – Business Description
Product Category: Akovaz
Overview
Performance
Product Category: Bloxiverz
Overview
Performance
Product Category: Other
Performance
Product Category: Vazculep
Overview
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: United States
Performance
Avadel Pharmaceuticals Plc – Corporate Strategy
Avadel Pharmaceuticals Plc – SWOT Analysis
SWOT Analysis – Overview
Avadel Pharmaceuticals Plc – Strengths
Avadel Pharmaceuticals Plc – Weaknesses
Avadel Pharmaceuticals Plc – Opportunities
Avadel Pharmaceuticals Plc – Threats
Avadel Pharmaceuticals Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2020: Avadel Pharmaceuticals reports fourth quarter and full year 2019 financial results
Feb 21, 2020: Avadel Pharmaceuticals announces $65 million Private Placement with leading biotech investment funds
Dec 10, 2019: Avadel Pharmaceuticals appoints Dr. Mark McCamish to its board of directors
Oct 04, 2019: Avadel announces resignation of Kevin Kotler from board of directors
Aug 09, 2019: Avadel Pharmaceuticals reports second quarter 2019 financial results and provides company update
Aug 01, 2019: Avadel Pharmaceuticals further strengthens clinical and medical team
May 08, 2019: Avadel Pharmaceuticals reports first quarter 2019 financial results
Mar 15, 2019: Avadel Pharmaceuticals reports fourth quarter and full year 2018 financial results
Feb 07, 2019: Avadel Pharmaceuticals clarifies announcement of corporate restructuring
Jan 03, 2019: Avadel Pharmaceuticals announces changes to management team and Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Avadel Pharmaceuticals Plc, Key Facts
Avadel Pharmaceuticals Plc, Key Employees
Avadel Pharmaceuticals Plc, Key Employee Biographies
Avadel Pharmaceuticals Plc, Major Products and Services
Avadel Pharmaceuticals Plc, History
Avadel Pharmaceuticals Plc, Subsidiaries
Avadel Pharmaceuticals Plc, Key Competitors
Avadel Pharmaceuticals Plc, Ratios based on current share price
Avadel Pharmaceuticals Plc, Annual Ratios
Avadel Pharmaceuticals Plc, Annual Ratios (Cont...1)
Avadel Pharmaceuticals Plc, Annual Ratios (Cont...2)
Avadel Pharmaceuticals Plc, Interim Ratios
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Avadel Pharmaceuticals Plc, Performance Chart (2015 - 2019)
Avadel Pharmaceuticals Plc, Ratio Charts
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hitachi Ltd (6501)-エネルギー分野:企業M&A・提携分析
    Summary Hitachi, Ltd. (Hitachi) is a multinational company with operations in sectors such as engineering and electronics, nuclear, transportation and industrial systems. It manufactures and sells information and telecommunication systems, power systems, social infrastructure and industrial systems, …
  • Waste Management, Inc.:企業の戦略・SWOT・財務分析
    Waste Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Waste Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • ConvaTec Group Plc (CTEC):企業の財務・戦略的SWOT分析
    ConvaTec Group Plc (CTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Petrosibir AB (SHEL B):企業の財務・戦略的SWOT分析
    Summary Petrosibir AB (Petrosibir) formerly Shelton Petroleum AB, is an oil and gas company. The company offers exploration and development of oil and gas assets and the resource-rich basins in Russia and Ukraine. It holds Ayazovskoye production license and Rustamovskoye exploration license that cov …
  • Aiful Corporation:企業の戦略・SWOT・財務情報
    Aiful Corporation - Strategy, SWOT and Corporate Finance Report Summary Aiful Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hydro-Quebec:企業の戦略的SWOT分析
    Hydro-Quebec - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Crown Van Gelder N.V.
    Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report Summary Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NorthWestern Corporation (NWE)-石油・ガス分野:企業M&A・提携分析
    Summary NorthWestern Corporation, doing business as NorthWestern Energy, is an integrated electric utility which generates, transmits, and distributes electricity and distributes natural gas in South Dakota, Nebraska and Montana. It produces energy from wind, hydro, natural gas, and coal-fired sourc …
  • ALLETE Inc (ALE):電力:M&Aディール及び事業提携情報
    Summary ALLETE Inc (ALLETE) is an energy company. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. The company generates electricity using coal, natural gas, biomass, hydro, wind, and solar; and procures energy thr …
  • Cielo Wind Power, LP-エネルギー分野:企業M&A・提携分析
    Summary Cielo Wind Power, LP (Cielo Wind) is a wind power project development company. It designs, develops, owns and operates utility-grade wind power projects. The company provides a wide range of services including engineering, construction, operations and maintenance, land procurement, meteorolo …
  • UCB SA (UCB):医療機器:M&Aディール及び事業提携情報
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • The Howa Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Howa Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Howa Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • SURUGA bank Ltd:企業の戦略・SWOT・財務情報
    SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report Summary SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • C&C Group plc:企業の戦略・SWOT・財務分析
    C&C Group plc - Strategy, SWOT and Corporate Finance Report Summary C&C Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Napp Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Wesfarmers Limited:企業の戦略・SWOT・財務情報
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BioView Ltd (BIOV):医療機器:M&Aディール及び事業提携情報
    Summary BioView Ltd (BioView) develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright-field microscopes fitted with hig …
  • Hindustan Petroleum Corporation Limited:企業の戦略・SWOT・財務情報
    Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • ImmunoCellular Therapeutics Ltd (IMUC):医療機器:M&Aディール及び事業提携情報
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆